Test selection should be a shared decision between patient and physician rather than directed by insurers’ test substitution policies, according to a statement published online in the Journal of the American College of Cardiology.[1] The statement summarizes the proceedings of a recent summit convened by the American Society of Nuclear Cardiology (ASNC), leadership of the American College of Cardiology Imaging Council, American Society of Echocardiography (ASE), Society of Cardiovascular Computed Tomography
News | Cardiac Imaging | September 22, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by...
Cardiothoracic surgeons with UofL Health – Jewish Hospital and the University of Louisville performed the world’s first Carmat Aeson bioprosthetic total artificial heart implantation in a female patient on Sept. 14, 2021. The device was small enough to fit into the woman's smaller chest cavity. The device is being tested as a bridge to heart transplant rather than use of a LVAD. Photo by UofL Health.

Cardiothoracic surgeons with UofL Health – Jewish Hospital and the University of Louisville performed the world’s first Carmat Aeson bioprosthetic total artificial heart implantation in a female patient on Sept. 14, 2021. The device was small enough to fit into the woman's smaller chest cavity. The device is being tested as a bridge to heart transplant rather than use of a LVAD. Photo by UofL Health.

News | Heart Failure | September 22, 2021
September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has...
ESC Releases Guidelines on Heart Failure Management
News | Heart Failure | September 21, 2021
September 21, 2021 — The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and...
Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.
News | Cath Lab | September 21, 2021
September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device...
Videos | Structural Heart | September 20, 2021
Dr. Neil Moat, MBBS, chief medical officer of Abbott's structural heart business, explains the latest advances in...
The U.S. Food and Drug Administration (FDA) has cleared the company's Portico with FlexNav transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery. 

The U.S. Food and Drug Administration (FDA) has cleared the company's Portico with FlexNav transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery. 
 

Feature | Structural Heart Occluders | September 20, 2021 | By Dave Fornell, Editor
September 20, 2021 — Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared the company's...
A rise in coronavirus, COVID-19, has prompted the American Heart Association (AHA) to cancel plans for an in-person, annual meeting in November and again host a virtual meeting instead. Getty images #AHA21 #AHA

A rise in coronavirus, COVID-19, has prompted the American Heart Association (AHA) to cancel plans for an in-person, annual meeting in November and again host a virtual meeting instead.

News | AHA | September 20, 2021
September 20, 2021 — The American Heart Association (AHA) announced Sept. 16 it decided to convert from a planned in-...
Videos | Congenital Heart | September 15, 2021
Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team...
Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get...
Us2.ai has received U.S. Food and Drug Administration (FDA) clearance for its artificial intelligence (AI) Us2.v1 software, a completely automated decision support tool for echocardiography.
News | Cardiovascular Ultrasound | September 14, 2021
September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food...
MedAxiom conducetd a survey of hospitals that offer cardiac rehab, cardiovascular rehabilitation, programs to find out the costs, how they are staffed and how they are implemented.

Getty Images

News | Cardiac Rehabilitation | September 14, 2021
September 14, 2021 – MedAxiom, an American College of Cardiology (ACC) company, released a report detailing cardiac...
Non-invasive evaluation of heart valves using echocardiography first, and other cardiac imaging techniques when needed, is the key evaluation of heart valves in the new ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease. Photo by Dave Fornell.

Non-invasive evaluation of heart valves using echocardiography first, and other cardiac imaging techniques when needed, is the key evaluation of heart valves in the new ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease. Photo by Dave Fornell.

News | Structural Heart | September 13, 2021
September 13, 2021 — The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (...
A nurse at Banner Health ion Phoenix, Ariz., adjusts an ECMO unit being used to support a severely ill COVID-19 patient. A new study finds high levels of moral distress among clinicians who regularly care for patients receiving mechanical circulatory support such as ECMO.

A nurse at Banner Health in Phoenix, Ariz., enters a room to adjust an ECMO unit being used to support a severely ill COVID-19 patient. A new study finds high levels of moral distress among clinicians who regularly care for patients receiving mechanical circulatory support such as ECMO.

News | ECMO Systems | September 13, 2021
September 13, 2021 — The growing use of mechanical circulatory support (MCS) may contribute to high levels of moral...
Ablation and Biventricular Pacing Boosts Survival in Selected Atrial Fibrillation Patients in APAF-CRT Trial. #ESC #ESCcongress
News | Atrial Fibrillation | September 13, 2021
September 13, 2021 — Ablation plus cardiac resynchronization therapy (CRT) is superior to pharmacological rate control...
Videos | September 13, 2021
About 80% of cardiovascular diseases (CVD) are preventable. This is why it is important to identify the people at...